GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Monaldi Archives for Chest Disease, PAGEPress Publications, Vol. 82, No. 1 ( 2015-08-19)
    Abstract: RE-START is a multicenter, randomized, prospective, open, controlled trial aiming to evaluate the feasibility and the short- and medium-term effects of an earlystart AET program on functional capacity, symptoms and neurohormonal activation in chronic heart failure (CHF) patients with recent acute hemodynamic decompensation. Study endpoints will be: 1) safety of and compliance to AET; 2) effects of AET on i) functional capacity, ii) patient- reported symptoms and iii) AET-induced changes in beta-adrenergic receptor signaling and circulating angiogenetic and inflammatory markers. Two-hundred patients, randomized 1:1 to training (TR) or control (C), will be enrolled. Inclusion criteria: 1) history of systolic CHF for at least 6 months, with ongoing acute decompensation with need of intravenous diuretic and/or vasodilator therapy; 2) proBNP & gt;1000 pg/ml at admission. Exclusion criteria: 1) ongoing cardiogenic shock; 2) need of intravenous inotropic therapy; 3) creatinine & gt;2.5 mg/dl at admission. After a 72-hour run-in period, TR will undergo the following 12-day early-start AET protocol: days 1-2: active/passive mobilization (2 sessions/day, each 30 minutes duration); days 3-4: as days 1-2 + unloaded bedside cycle ergometer (3 sessions/day, each 5-10 minutes duration); days 5-8: as days 1-2 + unloaded bedside cycle ergometer (3 sessions/day, each 15-20 minutes duration); days 9-12: as days 1-2 + bedside cycle ergometer at 10-20 W (3 sessions/day, each 15-20 minutes duration). During the same period, C will undergo the same activity protocol as in days 1-2 for TR. All patients will undergo a 6- minWT at day 1, 6, 12 and 30 and echocardiogram, patient- reported symptoms on 7-point Likert scale and measurement of lymphocyte G protein coupled receptor kinase, VEGF, angiopoietin, TNF alfa, IL-1, IL-6 and eNOS levels at day 1, 12 and 30.
    Type of Medium: Online Resource
    ISSN: 1122-0643
    Language: Unknown
    Publisher: PAGEPress Publications
    Publication Date: 2015
    detail.hit.zdb_id: 2375904-5
    detail.hit.zdb_id: 2375907-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Monaldi Archives for Chest Disease, PAGEPress Publications, Vol. 76, No. 3 ( 2015-12-09)
    Abstract: Over the years left ventricular assist devices (VADs) have become more durable and reliable, smaller, simpler, easier to implant and more comfortable. The extensive experience now acquired shows successful hospital discharge with VAD use. We are entering an era in which long-term mechanical circulatory support will play an increasing role in the approach to end-stage heart failure (HF); at the same time, the extension of VADs into destination therapy has revealed the limitations of our understanding of these populations. This second paper on cardiovascular prevention and rehabilitation for patients with left VADs will deal with the management of patients outside the highly specialized HF centers and surgical setting, with particular focus on postoperative patient management. Outpatient management of VAD patients is time-intensive, and a multidisciplinary approach is ideal in long-term care. Although the new devices have definite advantages over the older pumps, some challenges still remain, i.e. infection, stroke, device thrombosis, gastrointestinal bleeding, recurrent HF symptomatology with or without multisystem organ failure, and occurrence of ventricular arrhythmias.
    Type of Medium: Online Resource
    ISSN: 1122-0643
    Language: Unknown
    Publisher: PAGEPress Publications
    Publication Date: 2015
    detail.hit.zdb_id: 2375904-5
    detail.hit.zdb_id: 2375907-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    PAGEPress Publications ; 2016
    In:  Monaldi Archives for Chest Disease Vol. 70, No. 1 ( 2016-01-26)
    In: Monaldi Archives for Chest Disease, PAGEPress Publications, Vol. 70, No. 1 ( 2016-01-26)
    Abstract: Endothelial function measured with brachial ultrasound (BU) is a validated prognostic factor in heart failure patients. LVAD (left ventricle assist device) application is a promising surgical technique to treat refractory heart failure patients both as a bridge to heart transplantation or as destination therapy. Clinical recovery in such patients may be associated to normal endothelial function measured by BU but, as recently reported, only in pulsatile flow LVAD patients. The present paper report a case of normal endothelial function even in a axial LVAD patient.
    Type of Medium: Online Resource
    ISSN: 2465-1028 , 1122-0643
    Language: Unknown
    Publisher: PAGEPress Publications
    Publication Date: 2016
    detail.hit.zdb_id: 2375904-5
    detail.hit.zdb_id: 2375907-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Monaldi Archives for Chest Disease, PAGEPress Publications, Vol. 76, No. 1 ( 2015-12-09)
    Abstract: In the present context of an aging population, limited donor heart availability, improved reliability of mechanical cardiac support and improved patient outcomes, ventricular assist device (VAD) options to support end-stage heart failure patients are rapidly expanding. In addition, both the smaller size and lighter weight of the pumps now produced and early evidence that these third generation devices may be associated with lower risk of infection and right ventricular failure will probably lead to greater physician and patient acceptability. This is the first of a two-part review on the role of cardiovascular prevention and rehabilitation in patients with VAD. In this first part, we will discuss the role of exercise therapy in VAD patients, while the second will focus on long-term management. One of the prerequisites for use of a VAD - whether permanent (as destination therapy) or semi-permanent (as an alternative to heart transplantation) - is that exercise capacity, although not normal, must be adequate for daily life activities. An intensive multidisciplinary rehabilitation program has the potential to increase exercise performance and improve the quality of life of VAD patients. Both early progressive mobilization and exercise training may improve the overall condition of VAD patients, and favorably impact their clinical course.
    Type of Medium: Online Resource
    ISSN: 1122-0643
    Language: Unknown
    Publisher: PAGEPress Publications
    Publication Date: 2015
    detail.hit.zdb_id: 2375904-5
    detail.hit.zdb_id: 2375907-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...